Drinking to Excess? Psychedelics Can Help
Clearmind Medicine CEO Adi Zuloff-Shani writes this guest blog about how a new psychoactive molecule called MEAI can treat alcoholism.
Clearmind Medicine CEO Adi Zuloff-Shani writes this guest blog about how a new psychoactive molecule called MEAI can treat alcoholism.
This week in psychedelic business news: Field Trip Health secures a patent; Core One Labs seeks more retail investors; a new CEO takes over GABA Therapeutics.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.